EUVIMEDEUVIMED entdecken
Leserbrief

Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma

Liam Wilson, Aline Atallah, Joan Miguel Romero

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04666-7 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Liam Wilson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada. liam.wilson@mail.mcgill.ca. Hauptthemen laut MEDLINE: Glioblastoma, Temozolomide, Bevacizumab, Brain Neoplasms. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTemozolomideBevacizumabBrain NeoplasmsNeoadjuvant TherapyHumansFemaleMiddle AgedMaleAntineoplastic Combined Chemotherapy ProtocolsAgedAntineoplastic Agents, AlkylatingAdult

Substanzen

TemozolomideBevacizumabAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada. liam.wilson@mail.mcgill.ca.
  • Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.

Zitieren

APA

Wilson, L., Atallah, A., & Romero, J. M. (2024). Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04666-7

Vancouver

Wilson L, Atallah A, Romero JM. Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04666-7

BibTeX
@article{Wilson2024,
  author = {Wilson, Liam and Atallah, Aline and Romero, Joan Miguel},
  title = {Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04666-7}
}
Kostenlos starten →